InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| QUANTI-Luc™: Luciferase Detection Reagent | Microtubule-destabilizing agents enhance STING-mediated innate immune respons... | 2023 | Biomed Pharmacother. | Lim S. et al. | DOI: 10.1016/j.biopha.2023.115883 |
| QUANTI-Blue™ | Microtubule-destabilizing agents enhance STING-mediated innate immune respons... | 2023 | Biomed Pharmacother. | Lim S. et al. | DOI: 10.1016/j.biopha.2023.115883 |
| LPS-EB VacciGrade™ | Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 a... | 2023 | Sci Immunol. | Wattenberg M.M. et al. | DOI: 10.1126/sciimmunol.adj5097 |
| R848 VacciGrade™ | Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 a... | 2023 | Sci Immunol. | Wattenberg M.M. et al. | DOI: 10.1126/sciimmunol.adj5097 |
| MDP | Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 a... | 2023 | Sci Immunol. | Wattenberg M.M. et al. | DOI: 10.1126/sciimmunol.adj5097 |
| DMXAA | Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 a... | 2023 | Sci Immunol. | Wattenberg M.M. et al. | DOI: 10.1126/sciimmunol.adj5097 |
| Pam3CSK4 VacciGrade™ | Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 a... | 2023 | Sci Immunol. | Wattenberg M.M. et al. | DOI: 10.1126/sciimmunol.adj5097 |
| Poly(I:C) (HMW) VacciGrade™ | CD8+ T Cell-Dependent Antitumor Activity In Vivo of a Mass Spectrometry-Ident... | 2023 | J Immunol. | Gillig M.A. et al. | DOI: 10.4049/jimmunol.2300356 |
| MG-132 | The key cellular senescence related molecule RRM2 regulates prostate cancer p... | 2023 | Cell Biosci. | Cheng B. et al. | DOI: 10.1186/s13578-023-01157-6 |
| Curdlan | Prime-boost-type PspA3 + 2 mucosal vaccine protects cynomolgus macaques from ... | 2023 | Inflamm Regen. | Yokota C. et al. | DOI: 10.1186/s41232-023-00305-2 |
| LPS-EB (LPS from E. coli O111:B4) | O-GlcNAc modification of GSDMD attenuates LPS-induced endothelial cells pyrop... | 2023 | Inflamm Res. | Yu F. et al. | DOI: 10.1007/s00011-023-01812-1 |
| Anti-βGal-hCD3 | UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against dif... | 2023 | Br J Haematol. | Caracciolo D. et al. | DOI: 10.1111/bjh.19183 |
| Poly(dA:dT) | RNA methyltransferase FTSJ3 regulates the type I interferon pathway to promot... | 2023 | Cancer Res. | Zhuang Q. et al. | DOI: 10.1158/0008-5472.CAN-23-2049 |
| Poly(I:C) HMW | RNA methyltransferase FTSJ3 regulates the type I interferon pathway to promot... | 2023 | Cancer Res. | Zhuang Q. et al. | DOI: 10.1158/0008-5472.CAN-23-2049 |
| Primocin® | Generation of an iPSC line (RMCGENi020-A) from a patient with Stargardt disea... | 2023 | Stem Cell Res. | Suárez-Herrera N. et al. | DOI: 10.1016/j.scr.2023.103252 |
| Recombinant anti-mouse PD-1 antibody - Clone RMP1-14 (D265A) | STING activation counters glioblastoma by vascular alteration and immune surv... | 2023 | Cancer Lett. | Joseph J.V. et al. | DOI: 10.1016/j.canlet.2023.216480 |
| cAIM(PS)2 Difluor (Rp/Sp) (CL656) | STING activation counters glioblastoma by vascular alteration and immune surv... | 2023 | Cancer Lett. | Joseph J.V. et al. | DOI: 10.1016/j.canlet.2023.216480 |
| LPS-EB (LPS from E. coli O111:B4) | Single-cell analysis reveals a weak macrophage subpopulation response to Myco... | 2023 | Cell Rep. | Solomon S. & Bryson B.D. | DOI: 10.1016/j.celrep.2023.113418 |
| R848 (Resiquimod) | Single-cell analysis reveals a weak macrophage subpopulation response to Myco... | 2023 | Cell Rep. | Solomon S. & Bryson B.D. | DOI: 10.1016/j.celrep.2023.113418 |
| Pam3CSK4 VacciGrade™ | Single-cell analysis reveals a weak macrophage subpopulation response to Myco... | 2023 | Cell Rep. | Solomon S. & Bryson B.D. | DOI: 10.1016/j.celrep.2023.113418 |